Fintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...

Equities research analysts at Wedbush reduced their Q2 2025 earnings per share (EPS) estimates for Meritage Homes in a report ...

In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target ...

Wedbush's Dan Ives believes buying Palantir Technologies Inc (NYSE:PLTR) stock right now could be like buying Tesla Inc ...

Wedbush Securities, a leading financial services and investment firm, is proud to announce the launch of fast and efficient services for easy-to-borrow, locates and hard-to-borrow securities. This ...

Dan Ives, Wedbush Securities global head of technology research, joins 'Squawk on the Street' to discuss Ives' biggest ...

Equities research analysts at Wedbush dropped their Q1 2025 earnings estimates for shares of Meritage Homes in a report issued on Monday, February 3rd. Wedbush analyst J. Mccanless now forecasts that ...

Wedbush Securities hired Jefferies Financial Group Inc. banker Michael Murrer as head of gaming, lodging and leisure investment banking. Murrer, who’s based in New York, will report to Wedbush ...

Wedbush analyst Jay McCanless reiterated a Hold rating on Cavco Industries (CVCO – Research Report) today and set a price target of $550.00.

Wedbush analyst Matt Bryson lowered the firm’s price target on Intel (INTC) to $20 from $25 and keeps a Neutral rating on the ...

Palantir Technologies shares soared to an all-time high Tuesday after the company's outlook blew past analysts' expectations on strong demand for AI.